Announce Date | 02/04/2025 |
EPS Normalized Actual | $8.13 (Beat by $0.12) |
EPS GAAP Actual | $8.13 (Beat by $0.12) |
Revenue Actual | $2.223B |
Revenue Surprise | Beat by $2223M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2025 | 15.495 | 19.5 | 13.78 | 16.84 | 4 |
Dec 2024 | 13.22286 | 22.85 | 12.21 | 14.83 | 12 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.34 | 2.34 | 2.223B | -5.31% | 2223M |
FQ4 2024 (Dec 2024) | 12.34 | 12.34 | 3.035B | 3.99% | 3035M |
FQ3 2024 (Sep 2024) | -20.41 | -20.41 | 1.815B | -19.34% | 1815M |
FQ2 2024 (Jun 2024) | 1.37 | 1.37 | 2.266B | 4.72% | 2266M |
FQ3 2023 (Sep 2023) | 1.3 | 1.3 | 2.166B | 100% | 2166M |
FQ4 2023 (Dec 2023) | 5.98 | 5.98 | 2.914B | 100% | 2914M |
FQ1 2024 (Mar 2024) | 1.84 | 1.84 | 2.341B | 100% | 2341M |
FQ1 2001 (Mar 2001) | 0.82 | 0.82 | 0.375B | 100% | 375M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 10.6921 | -- | 10.50033 | 11.00537 | 8 |
FQ3 2027 (Sep 2027) | 3.74655 | -- | 3.71149 | 3.8063 | 5 |
FQ2 2027 (Jun 2027) | 3.10515 | -- | 3.0761 | 3.15467 | 5 |
FQ1 2027 (Mar 2027) | 4.3866 | -- | 4.34555 | 4.45655 | 5 |
FQ4 2026 (Oct 2026) | 3.81985 | -- | 3.76468 | 3.89379 | 9 |
FQ3 2026 (Jul 2026) | 3.0496 | -- | 3.00555 | 3.10863 | 9 |
FQ2 2026 (Jun 2026) | 3.1408 | -- | 3.10412 | 3.19183 | 9 |
FQ1 2026 (Mar 2026) | 4.43415 | 47.23 | 4.38237 | 4.50619 | 9 |
FQ4 2025 (Oct 2025) | 3.1458 | -292.27 | 3.10036 | 3.2067 | 6 |
FQ3 2025 (Sep 2025) | 3.13335 | 751.38 | 3.09676 | 3.18426 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.36B | -- | 3.32B | 3.44B | 4 |
FQ3 2027 (Sep 2027) | 2.57B | -- | 2.55B | 2.6B | 5 |
FQ2 2027 (Jun 2027) | 2.59B | -- | 2.57B | 2.62B | 4 |
FQ1 2027 (Mar 2027) | 2.69B | -- | 2.67B | 2.72B | 8 |
FQ4 2026 (Oct 2026) | 2.6B | -- | 2.58B | 2.64B | 4 |
FQ3 2026 (Jul 2026) | 2.6B | -- | 2.57B | 2.64B | 4 |
FQ2 2026 (Jun 2026) | 2.58B | -- | 2.56B | 2.62B | 6 |
FQ1 2026 (Mar 2026) | 2.68B | 17.17 | 2.66B | 2.72B | 4 |
FQ4 2025 (Oct 2025) | 2.4B | -26.21 | 2.38B | 2.44B | 3 |
FQ3 2025 (Sep 2025) | 2.39B | 24.06 | 2.37B | 2.42B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.34 | 2.34 | 100% | |
FQ4 2024 (Dec 2024) | 12.34 | 12.34 | 100% | |
FQ3 2024 (Sep 2024) | -20.41 | -20.41 | 100% | |
FQ2 2024 (Jun 2024) | 1.37 | 1.37 | 100% | |
FQ3 2023 (Sep 2023) | 1.3 | 1.3 | 100% | |
FQ4 2023 (Dec 2023) | 5.98 | 5.98 | 100% | |
FQ1 2024 (Mar 2024) | 1.84 | 1.84 | 100% | |
FQ1 2001 (Mar 2001) | 0.82 | 0.82 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $2.22B | $2223M | 100% |
FQ4 2024 (Dec 2024) | $0B | $3.04B | $3035M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.82B | $1815M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.27B | $2266M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.17B | $2166M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.91B | $2914M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.34B | $2341M | 100% |
FQ1 2001 (Mar 2001) | $0B | $0.38B | $375M | 100% |